Searchable abstracts of presentations at key conferences in endocrinology

ea0037gp.09.06 | Nuclear receptors and signalling | ECE2015

Effects of estrogens on endothelial-derived factors implicated in the atheromatic plaque vulnerability-clarification of the molecular mechanisms

Ansari Narjes Nasiri , Spilioti Eliana , Kalotychou Vasiliki , Dalman-Wright Karin , Moutsatsou Paraskevi , Papavassiliou Athanasios , Kassi Eva

Introduction: In the presence of atherogenic plaque, estrogens may be potentially harmful. Among the key vessel wall components in the later stages of atherogenic process are endothelial cells (ECs). During the stages of plaque instability/rupture, metalloproteinases (MMP2 and MMP9), their inhibitors (TIMP2 and TIMP1), RANK, RANKL, OPG, MCP1, lysyl oxidase (LOX), PDGF, and ADAMTS4 play critical role. We aimed to investigate i) the effect of oestrogens on the expression of the ...

ea0022p127 | Cardiovascular endocrinology and lipid metabolism | ECE2010

Subjects homozygous for the BCL1 polymorphism of glucocorticoid receptor gene may have an increased risk for impaired endothelial function

Stamatelopoulos Kimon , Saltiki Katerina , Mantzou Emily , Voidonikola Paraskevi , Papamichael Christos , Alevizaki Maria

Objectives: Glucocorticoids may affect cardiovascular risk. Polymorphisms in the glucocorticoid receptor (GlucR) gene have been associated with increased risk for cardiovascular disease. We investigated whether the common Bcl1 polymorphism of the GlucR gene (associated with increased sensitivity to glucocorticoids) may be associated with early markers of atherosclerosis.Methods: Two hundred and fourteen middle aged apparently healthy subjects (age &#8230...

ea0020p30 | Adrenal | ECE2009

Study of hormonal activity and insulin resistance in patients harbouring incidentally discovered bilateral adrenal adenomas

Androulakis Ioannis , Papanastasiou Lambrini , Tsenilklidi Ermioni , Prevoli Anastasia , Kafritsa Paraskevi , Pappa Theodora , Tsiavos Vaios , Piaditis George

Background: Hormonal activity and insulin resistance (IR) in patients with incidentally discovered bilateral adrenal adenomas (BA) has not been evaluated until now. Therefore, we have investigated cortisol and aldosterone secretion and IR in 29 patients with BA, in 113 patients with unilateral adrenal adenomas (UA) and in 89 healthy subjects (C).Methods: All subjects underwent the following investigation: 1) Low dose dexamethasone suppression test (LDDST...

ea0020p355 | Diabetes and Cardiovascular | ECE2009

Endogenous estrogen levels are associated with endothelial function in males independently of lipid levels

Saltiki Katerina , Stamatelopoulos Kimon , Voidonikola Paraskevi , Mantzou Emily , Papamichael Christos , Alevizaki Maria

Introduction-aim: It has been suggested that estrogen may play an important role in the regulation of endothelium-dependent vasodilatation in both sexes. Especially in men, estradiol administration has been shown to improve endothelial function; however such reports are conflicting. The aim of our study was to examine the relation of endogenous sex hormone levels with markers of early atherosclerosis in a cohort of apparently healthy individuals.Methods:...

ea0020p455 | Obesity and Metabolism | ECE2009

Thyroid function tests, measures of adiposity and metabolic syndrome in apparently healthy euthyroid individuals

Saltiki Katerina , Stamatelopoulos Kimon , Voidonikola Paraskevi , Mantzou Emily , Papamichael Christos , Alevizaki Maria

Objective: Thyroid function tests (TFTs) have been associated with obesity; however associations with the type of adiposity have not been examined. Ultrasound (U/S) was used to assess regional adiposity in euthyroid individuals. Associations of thyroid function with obesity parameters and presence of the metabolic syndrome (MS) were investigated.Methods: Of 302 apparently healthy slightly overweight individuals (age 42.9±8.8, BMI 19.0–43.3, med...

ea0014p234 | (1) | ECE2007

Association of sex hormone-binding globulin (shbg) levels with measures of adiposity and metabolic profile in apparently healthy individuals

Saltiki Katerina , Voidonikola Paraskevi , Stamatelopoulos Kimon , Mantzou Emily , Chryssohoou Eleftheria , Papamichael Christos , Alevizaki Maria

Objective: The association of SHBG levels with obesity, hyperinsulinemia and metabolic abnormalities is well recognized in both men and women. Recent data suggest that SHBG levels are an important predictor of cardiovascular disease (CVD) risk. Several methods have been used for the measurement of adiposity including ultrasonography (U/S) which is a reliable and low-cost method. We used U/S to assess regional adiposity and investigated possible associations with SHBG levels.</...

ea0014p423 | (1) | ECE2007

Percutaneous ethanol injection therapy in patients with primary and secondary hyperparathyroidism

Stratigis Spyros , Stylianou Kostas , Mamalaki Evangelia , vardaki Eleftheria , Tzenakis Nikolaos , Katsipi Eirini , Tzoutzouraki Paraskevi , Dafnis Eugenios

Introduction: Recent years PEIT has been introduced as an alternative to parathyroidectomy. We evaluated the results of PEIT in patients with primary (pHPT) or secondary hyperparathyroidism (sHPT).Patients and methods: 18 patients (6M/12F) with pHPT and 20 patients (7M/13F) with sHPT underwent PEIT between 2001 and 2005 and had a mean follow up of 24.3±9 and 27±10 months respectively. The PTGs were identified and blood supply to the gland was e...

ea0056gp192 | Pituitary / Growth Hormone ' IGF Axis | ECE2018

A case series of endocrine immune-related adverse effects of checkpoint inhibitors

Adamidou Fotini , Georgiou Thomas , Kafantari Katerina , Komzia Paraskevi , Vagionas Anastasios , Kita Marina

Background: With the increasing use of cancer immunotherapies in advanced solid organ and hematologic malignancies, endocrinologists are beckoned to manage endocrine complications with unique presentations and natural history in the already challenged oncology patient. We describe four patients illustrating the multifarious endocrine adversities of checkpoint inhibitors.Cases: Patient 1 is a 35-year old male with refractory Hodgkin’s lymphoma, previ...

ea0056p786 | Pituitary - Basic | ECE2018

Enhanced expression of the transcriptional activators YAP and TAZ in non-secreting pituitary tumours

Xekouki Paraskevi , Lodge Emily , Li Ran , Flitsch Jorg , Bornstein Stefan , Theodoropoulou Marily , Andoniadou Cynthia

The Hippo kinase cascade is a crucial signalling pathway regulating organ growth during development in numerous organs. There is mounting evidence implicating this signalling pathway in tumour formation, where it is emerging as an anti-cancer target due to effective pharmacological inhibition of its transcriptional activators YAP/TAZ. We previously demonstrated activity of the Hippo kinase cascade in the mouse pituitary and nuclear association of YAP/TAZ with SOX2 expressing p...

ea0056p787 | Pituitary - Basic | ECE2018

Activation of pituitary stem cells through modulation of the LATS/YAP/TAZ cascade

Lodge Emily , Russell John , Santambrogio Alice , Xekouki Paraskevi , Bornstein Stefan , Andoniadou Cynthia

Pituitary stem cells (PSCs) expressing SOX2 persist throughout life, giving rise to all pituitary endocrine lineages. These cells are highly active at early postnatal stages but this potential declines with age, rendering them mostly inactive in adulthood. The LATS/YAP/TAZ signaling cascade can influence stem cell fate and activity in multiple tissues and we previously identified activity of this axis in the developing and postnatal pituitary. Using a series of genetic manipul...